
Reset all filters
01 1PROCOS S.p.A.
Reset all filters
01 1Embutramide
Reset all filters
01 1Italy
NDC Package Code : 46016-0098
Start Marketing Date : 2006-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
63
PharmaCompass offers a list of Embutramide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Embutramide manufacturer or Embutramide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Embutramide manufacturer or Embutramide supplier.
PharmaCompass also assists you with knowing the Embutramide API Price utilized in the formulation of products. Embutramide API Price is not always fixed or binding as the Embutramide Price is obtained through a variety of data sources. The Embutramide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Embutane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Embutane, including repackagers and relabelers. The FDA regulates Embutane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Embutane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Embutane supplier is an individual or a company that provides Embutane active pharmaceutical ingredient (API) or Embutane finished formulations upon request. The Embutane suppliers may include Embutane API manufacturers, exporters, distributors and traders.
click here to find a list of Embutane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Embutane as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Embutane API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Embutane as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Embutane and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Embutane NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Embutane suppliers with NDC on PharmaCompass.